Sesen Bio Inc. (NASDAQ:SESN) finished Tuesday with a subtraction of -$0.05 to close at $0.73, a downside of -6.15 percent. An average of 7,106,120 shares of common stock have been traded in the last five days. There was a fall of -$0.0376 in the past week. The last 20 days have seen an average of 10,384,320 shares traded, while the 50-day average volume stands at 24,289,670.
SESN stock has decreased by -27.20% in the last month. The company shares reached their 1-month lowest point of $0.7280 on 10/06/21. With the stock rallying to its 52-week high on 08/13/21, shares of the company touched a low of $0.70 and a high of $6.04 in 52 weeks. In spite of this, the price is down -87.95% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sesen Bio Inc. (SESN) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 31.71 for the sector. This means investors are optimistic about the stock’s future prospects. In the last five years, Sesen Bio Inc.’s PE ratio has ranged between 58.75 and 4.619. The stock’s beta is 0.53. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 8.14, the price-to-book (PB) ratio at 2.60.
The quick ratio of Sesen Bio Inc. for the three months ended June 29 was 9.30, and the current ratio was 9.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Sesen Bio Inc.’s EBITDA margin for the year ending June 29 is -286.00%. Its gross profit as reported stood at $32.31 million compared to revenue of $11.24 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sesen Bio Inc.’s return on assets was -71.90%, compared to -36.0% over the last five years. For the broader industry, ROE averaged -68.79 over the past year.
The analyst consensus anticipated Sesen Bio Inc.’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.15, a -150.00% surprise. For the quarter, EBITDA amounted to -$25.36 million. Shareholders own equity worth $196.0 million.
From a technical analysis perspective, let’s take a brief look at Sesen Bio Inc. (SESN) price momentum. RSI 9-day as of the close on 05 October was 30.82%, suggesting the stock is Neutral, with historical volatility in this time frame at 59.10%.
As of today, SESN’s price is $0.7637 -4.91% or -$0.0376 from its 5-day moving average. SESN is currently trading -23.77% lower than its 20-day SMA and -68.89% lower than its 100-day SMA. However, the stock’s current price level is -81.04% below the SMA50 and -58.16% below the SMA200.
The stochastic %K and %D were 14.82% and 15.18%, respectively, and the average true range (ATR) was 0.0755. With the 14-day stochastic at 0.00% and the average true range at 0.1144, the RSI (14) stands at 30.83%. The stock has reached -0.0320 on the 9-day MACD Oscillator while the 14-day reading was at -0.0555.
H.C. Wainwright downgraded Sesen Bio Inc. (NASDAQ: SESN) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a a Buy.The consensus rating for Sesen Bio Inc. (SESN) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SESN, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is SESN’s price target for the next 12 months?
Analysts predict a range of price targets between $1.50 and $8.00, with a median target of $3.00. Taking a look at these predictions, the average price target given by analysts for Sesen Bio Inc. (SESN) stock is $4.17.